Project Grant R35GM161641
- Federal Grant Award Summary The University of Pittsburgh received a $437,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 15, 2025, with a completion date of July 31, 2030. This five-year award supports the development of advanced computational approaches for integrating single-cell multi-omics data across multiple platforms and cohorts. The project addresses critical...
- Federal Project Grant Award Summary The University of Pittsburgh received a $275,303 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2025, with completion targeted for July 31, 2030. This five-year research initiative develops predictive stochastic modeling frameworks to understand noise and variability in microbial cell proliferation across molecular, cellular, and...
- Federal Grant Award Summary The University of Pittsburgh received a $434,212 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through December 31, 2030. This award supports fundamental research investigating the mechanistic basis of DNA replication initiation in human cells. The project employs integrated cell biology, genetic, and proteomic approaches to identify novel...
- Federal Project Grant Award Summary The University of Pittsburgh received a $397,500 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 4, 2025 through August 31, 2030. This award supports fundamental research investigating the evolution and adaptation of Staphylococcus aureus to nutrient stress within host environments. The research focuses on understanding how this pathogenic...
- Federal Grant Award Summary The University of Pittsburgh received a $401,939 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with a completion date of June 30, 2030. This five-year research initiative focuses on post-translocation secretion chaperones in gram-positive bacteria, specifically examining the protein folding, stabilization, and activity mechanisms that...
- Federal Project Grant Award Summary The University of Pittsburgh received a $452,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025, through April 30, 2030. This five-year award funds fundamental research to elucidate the mechanisms by which nuclear speckles—membrane-less organelles within the cell nucleus—function as sensors and regulators of proteostasis (protein...
- Federal Grant Award Summary The University of Pittsburgh received a $437,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. The award supports research focused on improving the characterization of individualized treatment effects (ITEs) in critical illness, specifically addressing heterogeneity of treatment response in sepsis and acute...
- Federal Grant Award Summary The University of Pittsburgh has received a $430,170 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of July 9, 2025 and completion deadline of June 30, 2027. This project will deliver research services focused on identifying viral genetic determinants of Enterovirus D68 (EV-D68) neuropathogenesis using an innovative human spinal cord...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pittsburgh a $371,141 Project Grant on August 6, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and deploy the Fundamentals in Bioinformatics (FUNINBIO) continuing education program. The award, which extends through July 31, 2030, will deliver a three-part bioinformatics curriculum consisting of programming background instruction, an...
- Federal Grant Award Summary The University of Pittsburgh received a $790,847 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 10, 2026, with completion targeted for January 31, 2031. This award supports comprehensive research investigating HIV-1 resistance pathways against lenacapavir (LEN), a potent capsid inhibitor under investigation for both treatment and...
The University of Pittsburgh received a $417,620 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded on March 1, 2026, with a completion date of December 31, 2030. The grant supports the development of novel computational methods to quantify natural selection and predict evolutionary dynamics using temporal genetic data. The research team will create statistical tools that leverage mathematical methods from statistical physics to analyze sequences and phenotypes sampled over time, enabling the identification of genetic variants and phenotypes under selection while accounting for complex biological factors such as linkage disequilibrium, epistasis, and time-varying selection coefficients. The project will pursue three primary research directions: (1) developing methods to jointly analyze selection on individual mutations and phenotypic traits by integrating population genetics, quantitative genetics, and machine learning approaches; (2) applying these methods to study rapid evolution in viral pathogens with emphasis on understanding phenotypic changes; and (3) leveraging insights from previous research on HIV-1 immune escape and SARS-CoV-2 adaptation to build predictive models of evolutionary dynamics. The deliverables include computational algorithms, analytical frameworks, and applications to viral evolution studies that advance understanding of selection mechanisms relevant to emerging pathogen threats, drug resistance development, and protein engineering.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $417.6k | 2/27/26 |